• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

左心室致密化不全的肾功能障碍和结局。

Renal dysfunction and outcome in left ventricular non-compaction.

机构信息

Department of Cardiology, University Heart Center Zurich, Switzerland.

Department of Cardiology, University Hospital Basel, Switzerland.

出版信息

Cardiol J. 2023;30(5):781-789. doi: 10.5603/CJ.a2022.0105. Epub 2022 Nov 17.

DOI:10.5603/CJ.a2022.0105
PMID:36385602
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10635721/
Abstract

BACKGROUND

While renal function has been observed to inversely correlate with clinical outcome in other cardiomyopathies, its prognostic significance in patients with left ventricular non-compaction cardiomyopathy (LVNC) has not been investigated. The aim of this study was to determine the prognostic value of renal function in LVNC patients.

METHODS

Patients with isolated LVNC as diagnosed by echocardiography and/or magnetic resonance imaging in 4 Swiss centers were retrospectively analyzed for this study. Values for creatinine, urea, and estimated glomerular filtration rate (eGFR) as assessed by the CKD-EPI 2009 formula were collected and analyzed by a Cox regression model for the occurrence of a composite endpoint (death or heart transplantation).

RESULTS

During the median observation period of 7.4 years 23 patients reached the endpoint. The ageand gender-corrected hazard ratios (HR) for death or heart transplantation were: 1.9 (95% confidence interval [CI] 1.4-2.6) for each increase over baseline creatinine level of 30 μmol/L (p < 0.001), 1.6 (95% CI 1.2-2.2) for each increase over baseline urea level of 5 mmol/L (p = 0.004), and 3.6 (95% CI 1.9-6.9) for each decrease below baseline eGFR level of 30 mL/min (p ≤ 0.001). The HR (log2) for every doubling of creatinine was 7.7 (95% CI 3-19.8; p < 0.001), for every doubling of urea 2.5 (95% CI 1.5-4.3; p < 0.001), and for every bisection of eGFR 5.3 (95% CI 2.4-11.6; p < 0.001).

CONCLUSIONS

This study provides evidence that in patients with LVNC impairment in renal function is associated with an increased risk of death and heart transplantation suggesting that kidney function assessment should be standard in risk assessment of LVNC patients.

摘要

背景

虽然肾功能与其他心肌病的临床预后呈负相关,但在左心室心肌致密化不全(LVNC)患者中的预后意义尚未得到研究。本研究旨在确定肾功能在 LVNC 患者中的预后价值。

方法

本研究回顾性分析了瑞士 4 家中心通过超声心动图和/或磁共振成像诊断的孤立性 LVNC 患者。收集了血肌酐、尿素和通过 CKD-EPI 2009 公式评估的估算肾小球滤过率(eGFR)的值,并通过 Cox 回归模型分析了发生复合终点(死亡或心脏移植)的情况。

结果

在中位观察期 7.4 年内,23 例患者达到终点。每增加 30μmol/L 血肌酐水平,死亡或心脏移植的年龄和性别校正风险比(HR)为 1.9(95%置信区间 [CI] 1.4-2.6)(p<0.001),每增加 5mmol/L 血尿素水平,HR 为 1.6(95%CI 1.2-2.2)(p=0.004),每降低 30ml/min 基线 eGFR 水平,HR 为 3.6(95%CI 1.9-6.9)(p≤0.001)。血肌酐每增加 1 倍的 HR(log2)为 7.7(95%CI 3-19.8;p<0.001),血尿素每增加 1 倍的 HR 为 2.5(95%CI 1.5-4.3;p<0.001),eGFR 每减半的 HR 为 5.3(95%CI 2.4-11.6;p<0.001)。

结论

本研究提供的证据表明,在 LVNC 患者中,肾功能受损与死亡和心脏移植风险增加相关,这表明在 LVNC 患者的风险评估中应常规进行肾功能评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84e7/10635721/d506fb97acce/cardj-30-5-781f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84e7/10635721/5ef2fa214ab8/cardj-30-5-781f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84e7/10635721/48572c39741c/cardj-30-5-781f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84e7/10635721/d506fb97acce/cardj-30-5-781f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84e7/10635721/5ef2fa214ab8/cardj-30-5-781f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84e7/10635721/48572c39741c/cardj-30-5-781f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84e7/10635721/d506fb97acce/cardj-30-5-781f3.jpg

相似文献

1
Renal dysfunction and outcome in left ventricular non-compaction.左心室致密化不全的肾功能障碍和结局。
Cardiol J. 2023;30(5):781-789. doi: 10.5603/CJ.a2022.0105. Epub 2022 Nov 17.
2
Characteristics and long-term survival of patients with left ventricular non-compaction cardiomyopathy.左心室心肌致密化不全患者的特征和长期生存情况。
ESC Heart Fail. 2022 Dec;9(6):4219-4229. doi: 10.1002/ehf2.14081. Epub 2022 Sep 16.
3
Prognostic value of worsening renal function in outpatients with chronic heart failure.慢性心力衰竭门诊患者肾功能恶化的预后价值
Eur J Intern Med. 2014 Sep;25(7):662-8. doi: 10.1016/j.ejim.2014.06.002. Epub 2014 Jun 27.
4
Prognostic power of NT-proBNP in left ventricular non-compaction cardiomyopathy.N末端B型利钠肽原在左心室致密化不全心肌病中的预后价值
Int J Cardiol. 2017 Jun 1;236:321-327. doi: 10.1016/j.ijcard.2017.02.064. Epub 2017 Feb 24.
5
[The prognostic value of the method for determining the estimated glomerular filtration rate in chronic heart failure with a preserved left ventricular ejection fraction: focus on cystatin C].[估算肾小球滤过率测定方法在左心室射血分数保留的慢性心力衰竭中的预后价值:聚焦胱抑素C]
Kardiologiia. 2019 Sep 12;59(11S):69-76. doi: 10.18087/cardio.n338.
6
Isolated left ventricular non-compaction in adults: clinical and echocardiographic features in 105 patients. Results from a French registry.成人孤立性左心室心肌致密化不全:105 例患者的临床和超声心动图特征。法国注册研究结果。
Eur J Heart Fail. 2011 Feb;13(2):177-85. doi: 10.1093/eurjhf/hfq225. Epub 2010 Dec 29.
7
Prognostic assessment of estimated glomerular filtration rate by the new Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet in Renal Disease Study equation.新慢性肾脏病流行病学合作方程与肾脏病饮食改良研究方程估算肾小球滤过率的预后评估比较。
Am Heart J. 2011 Sep;162(3):548-54. doi: 10.1016/j.ahj.2011.06.006. Epub 2011 Aug 9.
8
Prognostic Effect of Renal Function in Ambulatory Patients With Heart Failure and Reduced Ejection Fraction: The Kidney Is a Marker of Cardiac Function.肾功能对射血分数降低的心力衰竭门诊患者预后的影响:肾脏是心脏功能的标志物。
Can J Cardiol. 2018 Oct;34(10):1325-1332. doi: 10.1016/j.cjca.2018.06.006. Epub 2018 Jun 15.
9
Association of renal biochemical parameters with left ventricular diastolic dysfunction in a community-based elderly population in China: a cross-sectional study.中国社区老年人群中肾脏生化指标与左心室舒张功能障碍的关联:一项横断面研究
PLoS One. 2014 Feb 12;9(2):e88638. doi: 10.1371/journal.pone.0088638. eCollection 2014.
10
Elevated urea level is associated with poor clinical outcome and increased mortality post intravenous tissue plasminogen activator in stroke patients.血尿素氮水平升高与静脉注射组织型纤溶酶原激活物后脑卒中患者的临床预后不良和死亡率增加相关。
J Neurol Sci. 2013 Sep 15;332(1-2):110-5. doi: 10.1016/j.jns.2013.06.030. Epub 2013 Jul 29.

本文引用的文献

1
Risk of end-stage renal disease in patients with hypertrophic cardiomyopathy: A nationwide population-based cohort study.肥厚型心肌病患者终末期肾病的风险:一项全国范围内基于人群的队列研究。
Sci Rep. 2019 Oct 10;9(1):14565. doi: 10.1038/s41598-019-50993-5.
2
Right ventricle and outcome in left ventricular non-compaction cardiomyopathy.左心室心肌致密化不全的右心室与预后。
J Cardiol. 2020 Jan;75(1):20-26. doi: 10.1016/j.jjcc.2019.09.003. Epub 2019 Oct 4.
3
Prognostic power of NT-proBNP in left ventricular non-compaction cardiomyopathy.
N末端B型利钠肽原在左心室致密化不全心肌病中的预后价值
Int J Cardiol. 2017 Jun 1;236:321-327. doi: 10.1016/j.ijcard.2017.02.064. Epub 2017 Feb 24.
4
Heart failure and kidney dysfunction: epidemiology, mechanisms and management.心力衰竭与肾脏功能障碍:流行病学、发病机制与治疗。
Nat Rev Nephrol. 2016 Oct;12(10):610-23. doi: 10.1038/nrneph.2016.113. Epub 2016 Aug 30.
5
Long-term outcome and predictors of outcome in patients with non-ischemic dilated cardiomyopathy.非缺血性扩张型心肌病患者的长期预后及预后预测因素
Int J Cardiol. 2016 Oct 1;220:608-12. doi: 10.1016/j.ijcard.2016.06.167. Epub 2016 Jun 26.
6
Renal impairment and outcome in patients with takotsubo cardiomyopathy.Takotsubo心肌病患者的肾功能损害与预后
Am J Emerg Med. 2016 Mar;34(3):548-52. doi: 10.1016/j.ajem.2015.12.065. Epub 2015 Dec 23.
7
Biomarkers of renal injury and function: diagnostic, prognostic and therapeutic implications in heart failure.肾损伤和功能的生物标志物:心力衰竭中的诊断、预后和治疗意义。
Eur Heart J. 2016 Sep 1;37(33):2577-85. doi: 10.1093/eurheartj/ehv588. Epub 2015 Nov 4.
8
Prevalence, predictors, and outcomes of cardiorenal syndrome in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry.扩张型心肌病患儿心肾综合征的患病率、预测因素及结局:来自儿童心肌病注册研究的报告
Pediatr Nephrol. 2015 Dec;30(12):2177-88. doi: 10.1007/s00467-015-3165-8. Epub 2015 Jul 26.
9
Worsening renal function and outcome in heart failure patients with preserved ejection fraction and the impact of angiotensin receptor blocker treatment.射血分数保留的心力衰竭患者肾功能恶化和预后不良,以及血管紧张素受体阻滞剂治疗的影响。
J Am Coll Cardiol. 2014 Sep 16;64(11):1106-13. doi: 10.1016/j.jacc.2014.01.087.
10
Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function (PROTECT) Study.急性心力衰竭入院后短期信息获取对出院后结局的预测因素:选择性 A1 腺苷受体拮抗剂罗洛司琼治疗急性失代偿性心力衰竭和容量超负荷患者的安慰剂对照随机研究(PROTECT)的报告。
Circ Heart Fail. 2014 Jan;7(1):76-87. doi: 10.1161/CIRCHEARTFAILURE.113.000284. Epub 2013 Nov 26.